Evidence map›Paper›PMID 10079240›Full record

ReviewThe American journal of pathology1999

Genomic imprinting: implications for human disease.

J G Falls, D J Pulford, A A Wylie, R L Jirtle

Abstract readReview
In one paragraph

Review in The American journal of pathology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Clinical utility of genomic sequencing.Current opinion in pediatrics · 2019
    Review

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

J G FallsDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina27710, USA.
D J Pulford
A A Wylie
R L Jirtle

Funding

TUMOR SUPPRESSOR FUNCTION OF THE M6P/IGF2 RECEPTORR01ES008823 · NIEHS · DUKE UNIVERSITY · PI JIRTLE, RANDY L · 1997 to 2007
$2.2M
SURVIVAL AND CARCINOGENESIS IN TRANSPLANTED HEPATOCYTESR01CA025951 · NCI · DUKE UNIVERSITY · PI JIRTLE, RANDY L · 1985 to 2004
$1.4M
NCI NIH HHS CA25951NCI NIH HHS R01 CA025951NIEHS NIH HHS ES08823NIEHS NIH HHS R01 ES008823
6 · The paper itself

Abstract

Genomic imprinting refers to an epigenetic marking of genes that results in monoallelic expression. This parent-of-origin dependent phenomenon is a notable exception to the laws of Mendelian genetics. Imprinted genes are intricately involved in fetal and behavioral development. Consequently, abnormal expression of these genes results in numerous human genetic disorders including carcinogenesis. This paper reviews genomic imprinting and its role in human disease. Additional information about imprinted genes can be found on the Genomic Imprinting Website at http://www.geneimprint.com.

Indexed as

Genomic ImprintingAngelman SyndromeBeckwith-Wiedemann SyndromeBehaviorBrainHumansNeoplasmsPrader-Willi Syndrome

Identifiers

PMID10079240
PMCPMC1866410

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.